Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
A review of patient-reported outcome assessments in registration trials of FDA-approved new oncology drugs (2014-2018).
Contemp Clin Trials. 2022 Sep;120:106860. doi: 10.1016/j.cct.2022.106860. Epub 2022 Jul 25.
Contemp Clin Trials. 2022.
PMID: 35901962
Review.
Real-world burden of adverse events for apalutamide- or enzalutamide-treated non-metastatic castration-resistant prostate cancer patients in the United States.
Hussain A, Jiang S, Varghese D, Appukkuttan S, Kebede N, Gnanasakthy K, Macahilig C, Waldeck R, Corman S.
Hussain A, et al. Among authors: gnanasakthy k.
BMC Cancer. 2022 Mar 22;22(1):304. doi: 10.1186/s12885-022-09364-z.
BMC Cancer. 2022.
PMID: 35317768
Free PMC article.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.